{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:45:26Z","timestamp":1792759526286,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00066-022-01918-1","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T08:02:58Z","timestamp":1649404978000},"page":"558-565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Consolidative active scanning proton therapy for mediastinal lymphoma: selection criteria, treatment implementation and clinical feasibility"],"prefix":"10.1007","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-572X","authenticated-orcid":false,"given":"F.","family":"Dionisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Scartoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vennarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Righetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Farace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lorentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Di Murro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Demofonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"D\u2019Angelillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Petrongari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sanguineti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Amichetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"1918_CR1","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jacr.2018.07.020","volume":"15","author":"J Kerstiens","year":"2018","unstructured":"Kerstiens\u00a0J, Johnstone\u00a0GP, Johnstone\u00a0PAS (2018) Proton facility economics: single-room centers. J\u00a0Am Coll Radiol 15:1704\u20131708","journal-title":"J Am Coll Radiol"},{"key":"1918_CR2","unstructured":"PTCOG (2019) Patient statistics. https:\/\/www.ptcog.ch\/index.php\/patient-statistics. Accessed 28 July 2020"},{"key":"1918_CR3","unstructured":"Astro Model Policies (2014) Proton beam therapy. https:\/\/www.astro.org\/uploadedFiles\/Main_Site\/Practice_Management\/Reimbursement\/ASTRO%20PBT%20Model%20Policy%20FINAL.pdf. Accessed 29 July 2020"},{"key":"1918_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.radonc.2013.06.031","volume":"107","author":"C Grau","year":"2013","unstructured":"Grau\u00a0C (2013) The model-based approach to clinical studies in particle radiotherapy\u2014a new concept in evidence based radiation oncology? Radiother Oncol 107:265\u2013266","journal-title":"Radiother Oncol"},{"key":"1918_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/2319-4170.153211","volume":"38","author":"W-H Kao","year":"2015","unstructured":"Kao\u00a0W\u2011H, Shen\u00a0Y\u2011L, Hong\u00a0J\u2011H (2015) What are the potential benefits of using proton therapy in Taiwanese cancer patients? Biomed\u00a0J 38:391\u2013398","journal-title":"Biomed J"},{"key":"1918_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/0284186X.2020.1817977","volume":"59","author":"P Brandal","year":"2020","unstructured":"Brandal\u00a0P, Bergfeldt\u00a0K, Aggerholm-Pedersen\u00a0N, B\u00e4ckstr\u00f6m\u00a0G, Kerna\u00a0I, Gubanski\u00a0M et al (2020) A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients. Acta Oncol 59:1157\u20131163","journal-title":"Acta Oncol"},{"key":"1918_CR7","unstructured":"Gazzetta Ufficiale (2017) Decreto del presidente del consiglio dei ministri. https:\/\/www.gazzettaufficiale.it\/eli\/id\/2017\/03\/18\/17A02015\/sg. Accessed 18 Jan 2021"},{"key":"1918_CR8","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1200\/JCO.2016.70.9410","volume":"35","author":"S Sasse","year":"2017","unstructured":"Sasse\u00a0S, Br\u00f6ckelmann\u00a0PJ, Goergen\u00a0H, Pl\u00fctschow\u00a0A, M\u00fcller\u00a0H, Kreissl\u00a0S et al (2017) Long-term follow-up of contemporary treatment in early-stage Hodgkin lymphoma: updated analyses of the German Hodgkin study group HD7, HD8, HD10, and HD11 trials. J\u00a0Clin Oncol 35:1999\u20132007","journal-title":"J Clin Oncol"},{"key":"1918_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ijrobp.2010.10.069","volume":"82","author":"M Koshy","year":"2012","unstructured":"Koshy\u00a0M, Rich\u00a0SE, Mahmood\u00a0U, Kwok\u00a0Y (2012) Declining use of radiotherapy in stage I and II Hodgkin\u2019s disease and its effect on survival and secondary malignancies. Int J Radiat Oncol Biol Phys 82:619\u2013625","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1918_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.prro.2019.05.009","volume":"9","author":"AS Everett","year":"2019","unstructured":"Everett\u00a0AS, Hoppe\u00a0BS, Louis\u00a0D, McDonald\u00a0AM, Morris\u00a0CG, Mendenhall\u00a0NP et al (2019) Comparison of techniques for involved-site radiation therapy in patients with lower mediastinal lymphoma. Pract Radiat Oncol 9:426\u2013434","journal-title":"Pract Radiat Oncol"},{"key":"1918_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1088\/0031-9155\/44\/1\/014","volume":"44","author":"A Lomax","year":"1999","unstructured":"Lomax\u00a0A (1999) Intensity modulation methods for proton radiotherapy. Phys Med Biol 44:185\u2013205","journal-title":"Phys Med Biol"},{"key":"1918_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1078\/0939-3889-00217","volume":"14","author":"AJ Lomax","year":"2004","unstructured":"Lomax\u00a0AJ, Pedroni\u00a0E, Rutz\u00a0H, Goitein\u00a0G (2004) The clinical potential of intensity modulated proton therapy. Z\u00a0Med Phys 14:147\u2013152","journal-title":"Z Med Phys"},{"key":"1918_CR13","unstructured":"Particle Therapy Cooperative Group (2022) Website. http:\/\/ptcog.web.psi.ch\/ptcentres.html. Accessed 28 July 2020"},{"key":"1918_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.radonc.2020.09.035","volume":"154","author":"F Fracchiolla","year":"2021","unstructured":"Fracchiolla\u00a0F, Dionisi\u00a0F, Righetto\u00a0R, Widesott\u00a0L, Giacomelli\u00a0I, Cartechini\u00a0G et\u00a0al (2021) Clinical implementation of pencil beam scanning proton therapy for liver cancer with forced deep expiration breath hold. Radiother Oncol 154:137\u2013144","journal-title":"Radiother Oncol"},{"key":"1918_CR15","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","volume":"89","author":"L Specht","year":"2014","unstructured":"Specht\u00a0L, Yahalom\u00a0J, Illidge\u00a0T, Berthelsen\u00a0AK, Constine\u00a0LS, Eich\u00a0HT et\u00a0al (2014) Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys 89:854\u2013862","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1918_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","volume":"79","author":"M Feng","year":"2011","unstructured":"Feng\u00a0M, Moran\u00a0JM, Koelling\u00a0T, Chughtai\u00a0A, Chan\u00a0JL, Freedman\u00a0L et\u00a0al (2011) Development and validation of a\u00a0heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 79:10\u201318","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1918_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/0300891620937809","volume":"107","author":"F Dionisi","year":"2021","unstructured":"Dionisi\u00a0F, Brolese\u00a0A, Siniscalchi\u00a0B, Giacomelli\u00a0I, Fracchiolla\u00a0F, Righetto\u00a0R et\u00a0al (2021) Clinical results of active scanning proton therapy for primary liver tumors. Tumori 107:71\u201379","journal-title":"Tumori"},{"key":"1918_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.meddos.2018.02.013","volume":"43","author":"D Bodensteiner","year":"2018","unstructured":"Bodensteiner\u00a0D (2018) RayStation: external beam treatment planning system. Med Dosim 43:168\u2013176","journal-title":"Med Dosim"},{"key":"1918_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","volume":"53","author":"H Paganetti","year":"2002","unstructured":"Paganetti\u00a0H, Niemierko\u00a0A, Ancukiewicz\u00a0M, Gerweck\u00a0LE, Goitein\u00a0M, Loeffler\u00a0JS et\u00a0al (2002) Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 53:407\u2013421","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1918_CR20","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.ijrobp.2018.12.021","volume":"104","author":"A Gupta","year":"2019","unstructured":"Gupta\u00a0A, Khan\u00a0AJ, Goyal\u00a0S, Millevoi\u00a0R, Elsebai\u00a0N, Jabbour\u00a0SK et\u00a0al (2019) Insurance approval for proton beam therapy and its impact on delays in treatment. Int J Radiat Oncol Biol Phys 104:714\u2013723","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1918_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.prro.2019.01.006","volume":"9","author":"G Ntentas","year":"2019","unstructured":"Ntentas\u00a0G, Dedeckova\u00a0K, Andrlik\u00a0M, Aznar\u00a0MC, George\u00a0B, Kube\u0161\u00a0J et\u00a0al (2019) Clinical intensity modulated proton therapy for Hodgkin lymphoma: Which patients benefit the most? Pract Radiat Oncol 9:179\u2013187","journal-title":"Pract Radiat Oncol"},{"key":"1918_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ijrobp.2018.03.003","volume":"101","author":"CC Pinnix","year":"2018","unstructured":"Pinnix\u00a0CC, Cella\u00a0L, Andraos\u00a0TY, Ayoub\u00a0Z, Milgrom\u00a0SA, Gunther\u00a0J et al (2018) Predictors of hypothyroidism in Hodgkin lymphoma survivors after intensity modulated versus 3\u2011dimensional radiation therapy. Int J Radiat Oncol Biol Phys 101:530\u2013540","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1918_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00066-019-01460-7","volume":"195","author":"L K\u00f6nig","year":"2019","unstructured":"K\u00f6nig\u00a0L, Bougatf\u00a0N, H\u00f6rner-Rieber\u00a0J, Chaudhri\u00a0N, Mielke\u00a0T, Kl\u00fcter\u00a0S et al (2019) Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison. Strahlenther Onkol 195:677\u2013687","journal-title":"Strahlenther Onkol"},{"key":"1918_CR24","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1080\/0284186X.2016.1191665","volume":"55","author":"C Zeng","year":"2016","unstructured":"Zeng\u00a0C, Plastaras\u00a0JP, James\u00a0P, Tochner\u00a0ZA, Hill-Kayser\u00a0CE, Hahn\u00a0SM et al (2016) Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment. Acta Oncol 55:1132\u20131138","journal-title":"Acta Oncol"},{"key":"1918_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ijrobp.2014.01.041","volume":"89","author":"AR Filippi","year":"2014","unstructured":"Filippi\u00a0AR, Ciammella\u00a0P, Piva\u00a0C, Ragona\u00a0R, Botto\u00a0B, Gavarotti\u00a0P et al (2014) Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 89:370\u2013375","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1918_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx287","author":"BS Hoppe","year":"2017","unstructured":"Hoppe\u00a0BS et\u00a0al (2017) Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma. Annals of Oncology. https:\/\/doi.org\/10.1093\/annonc\/mdx287","journal-title":"Annals of Oncology"},{"key":"1918_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tipsro.2019.11.006","author":"KM Andersson","year":"2020","unstructured":"Andersson\u00a0KM et\u00a0al (2020) Pencil beam scanning proton therapy of Hodgkin\u2019s lymphoma in deep inspiration breath-hold: A case series report. Technical Innovations & Patient Support in Radiation Oncology. https:\/\/doi.org\/10.1016\/j.tipsro.2019.11.006","journal-title":"Technical Innovations & Patient Support in Radiation Oncology"},{"key":"1918_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.08.055","author":"YD Tseng","year":"2021","unstructured":"Tseng\u00a0YD et\u00a0al (2021) Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed\/Refractory Lymphoma: A\u00a0PTCOG and PCG Collaboration. International Journal of Radiation Oncology \u2022 Biology \u2022 Physics. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.055","journal-title":"International Journal of Radiation Oncology \u2022 Biology \u2022 Physics"},{"issue":"6","key":"1918_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/jnci\/djaa194","volume":"113","author":"S de Vries","year":"2021","unstructured":"de Vries\u00a0S, Schaapveld\u00a0M, Janus\u00a0CPM, Dani\u00ebls\u00a0LA, Petersen\u00a0EJ, van der Maazen\u00a0RWM et al (2021) Long-term cause-specific mortality in Hodgkin lymphoma patients. J\u00a0Natl Cancer Inst 113(6):760\u2013769","journal-title":"J Natl Cancer Inst"},{"key":"1918_CR30","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3389\/fonc.2020.00989","volume":"10","author":"L K\u00f6nig","year":"2020","unstructured":"K\u00f6nig\u00a0L, Haering\u00a0P, Lang\u00a0C, Splinter\u00a0M, von Nettelbladt\u00a0B, Weykamp\u00a0F et al (2020) Secondary malignancy risk following proton vs. X\u2011ray treatment of mediastinal malignant lymphoma: a comparative modeling study of thoracic organ-specific cancer risk. Front Oncol 10:989","journal-title":"Front Oncol"},{"key":"1918_CR31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby\u00a0SC, Ewertz\u00a0M, McGale\u00a0P, Bennet\u00a0AM, Blom-Goldman\u00a0U, Br\u00f8nnum\u00a0D et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N\u00a0Engl J Med 368:987\u2013998","journal-title":"N Engl J Med"},{"key":"1918_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13014-019-1242-z","volume":"14","author":"A-K Wennstig","year":"2019","unstructured":"Wennstig\u00a0A\u2011K, Garmo\u00a0H, Isacsson\u00a0U, Gagliardi\u00a0G, Rintel\u00e4\u00a0N, Lagerqvist\u00a0B et al (2019) The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors. Radiat Oncol 14:40","journal-title":"Radiat Oncol"},{"key":"1918_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13014-020-01504-8","volume":"15","author":"AR Filippi","year":"2020","unstructured":"Filippi\u00a0AR, Meregalli\u00a0S, Di Russo\u00a0A, Levis\u00a0M, Ciammella\u00a0P, Buglione\u00a0M et al (2020) Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin\u2019s lymphoma involving the mediastinum. Radiat Oncol 15:62","journal-title":"Radiat Oncol"},{"key":"1918_CR34","doi-asserted-by":"publisher","first-page":"100269","DOI":"10.1016\/j.eclinm.2020.100269","volume":"20","author":"A Desai","year":"2020","unstructured":"Desai\u00a0A, Gyawali\u00a0B (2020) Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions. EClinicalMedicine 20:100269","journal-title":"EClinicalMedicine"},{"key":"1918_CR35","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1053\/clon.2002.0174","volume":"15","author":"M Goitein","year":"2003","unstructured":"Goitein\u00a0M, Jermann\u00a0M (2003) The relative costs of proton and X\u2011ray radiation therapy. Clin Oncol (R Coll Radiol) 15:S37\u2013S50","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-01918-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-022-01918-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-01918-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T13:16:18Z","timestamp":1653311778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-022-01918-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1918"],"URL":"https:\/\/doi.org\/10.1007\/s00066-022-01918-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"F.\u00a0Dionisi, D.\u00a0Scartoni, B.\u00a0Rombi, S.\u00a0Vennarini, R.\u00a0Righetto, P.\u00a0Farace, S.\u00a0Lorentini, M.\u00a0Schwarz, L.\u00a0Di Murro, C.\u00a0Demofonti, R.M.\u00a0D\u2019Angelillo, M.G.\u00a0Petrongari, G.\u00a0Sanguineti and M.\u00a0Amichetti declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was waived by the local ethics committee in view of the retrospective nature of the analysis. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}